Marshall Wace’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-243,243
| Closed | -$1.09M | – | 2257 |
|
|
2024
Q1 | $1.09M | Buy |
243,243
+221,395
| +1,013% | +$994K | ﹤0.01% | 1409 |
|
|
2023
Q4 | $36.3K | Sell |
21,848
-416,825
| -95% | -$692K | ﹤0.01% | 1760 |
|
|
2023
Q3 | $395K | Buy |
438,673
+73,615
| +20% | +$66.3K | ﹤0.01% | 1503 |
|
|
2023
Q2 | $785K | Buy |
365,058
+207,379
| +132% | +$446K | ﹤0.01% | 1449 |
|
|
2023
Q1 | $307K | Buy |
+157,679
| New | +$307K | ﹤0.01% | 1809 |
|
|
2021
Q1 | – | Sell |
-59,567
| Closed | -$1.91M | – | 2059 |
|
|
2020
Q4 | $1.91M | Sell |
59,567
-136,085
| -70% | -$4.36M | 0.01% | 877 |
|
|
2020
Q3 | $6.46M | Buy |
+195,652
| New | +$6.46M | 0.04% | 405 |
|